{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T13:58:42Z","timestamp":1777039122110,"version":"3.51.4"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1097\/wco.0b013e3283531efb","type":"journal-article","created":{"date-parts":[[2012,4,6]],"date-time":"2012-04-06T20:38:23Z","timestamp":1333744703000},"page":"341-348","source":"Crossref","is-referenced-by-count":21,"title":["Neuron-directed autoimmunity in the central nervous system"],"prefix":"10.1097","volume":"25","author":[{"given":"Nico","family":"Melzer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven G.","family":"Meuth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz","family":"Wiendl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-19-20210206","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1055\/s-0031-1277985","article-title":"Autoimmune encephalopathy.","volume":"31","author":"Flanagan","year":"2011","journal-title":"Semin Neurol"},{"key":"R3-19-20210206","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00415-009-5431-9","article-title":"Antibodies and neuronal autoimmune disorders of the CNS.","volume":"257","author":"Graus","year":"2010","journal-title":"J Neurol"},{"key":"R4-19-20210206","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00401-011-0876-1","article-title":"Paraneoplastic encephalomyelopathies: pathology and mechanisms.","volume":"122","author":"McKeon","year":"2011","journal-title":"Acta Neuropathol"},{"key":"R5-19-20210206","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","article-title":"Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis.","volume":"30","author":"Hughes","year":"2010","journal-title":"J Neurosci"},{"key":"R6-19-20210206","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"R7-19-20210206","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/brain\/awq113","article-title":"N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly nonparaneoplastic disorder of both sexes.","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"R8-19-20210206","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol"},{"key":"R9-19-20210206","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma.","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"key":"R10-19-20210206","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1460-9568.2010.07349.x","article-title":"Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies.","volume":"32","author":"Moscato","year":"2010","journal-title":"Eur J Neurosci"},{"key":"R11-19-20210206","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.nbd.2011.09.019","article-title":"Suppression of synaptic plasticity by cerebrospinal fluid from anti-NMDA receptor encephalitis patients.","volume":"45","author":"Zhang","year":"2012","journal-title":"Neurobiol Dis"},{"key":"R12-19-20210206","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.21589","article-title":"AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location.","volume":"65","author":"Lai","year":"2009","journal-title":"Ann Neurol"},{"key":"R13-19-20210206","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1212\/WNL.0b013e3181d3e404","article-title":"The expanding clinical profile of anti-AMPA receptor encephalitis.","volume":"74","author":"Graus","year":"2010","journal-title":"Neurology"},{"key":"R14-19-20210206","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","article-title":"Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen.","volume":"9","author":"Lancaster","year":"2010","journal-title":"Lancet Neurol"},{"key":"R15-19-20210206","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1212\/01.wnl.0000327606.50322.f0","article-title":"Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody.","volume":"71","author":"Hutchinson","year":"2008","journal-title":"Neurology"},{"key":"R16-19-20210206","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1136\/jnnp.2010.229104","article-title":"Antiglycine-receptor encephalomyelitis with rigidity.","volume":"82","author":"Mas","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R17-19-20210206","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvans syndrome and acquired neuromyotonia.","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"R18-19-20210206","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","article-title":"Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series.","volume":"9","author":"Lai","year":"2010","journal-title":"Lancet Neurol"},{"key":"R19-19-20210206","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ana.22297","article-title":"Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia.","volume":"69","author":"Lancaster","year":"2011","journal-title":"Ann Neurol"},{"key":"R20-19-20210206","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM200001063420104","article-title":"Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor.","volume":"342","author":"Sillevis Smitt","year":"2000","journal-title":"N Engl J Med"},{"key":"R21-19-20210206","first-page":"627","article-title":"Metabotropic glutamate receptor type 1 autoantibody-associated cerebellitis: a primary autoimmune disease Arch N","volume":"67","author":"Marignier","year":"2010","journal-title":"eurol"},{"key":"R22-19-20210206","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/ana.10451","article-title":"Mechanisms underlying cerebellar motor deficits due to mGluR1-autoantibodies.","volume":"53","author":"Coesmans","year":"2003","journal-title":"Ann Neurol"},{"key":"R23-19-20210206","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0140-6736(82)91887-6","article-title":"The Ophelia syndrome: memory loss in Hodgkins disease.","volume":"1","author":"Carr","year":"1982","journal-title":"Lancet"},{"key":"R24-19-20210206","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1212\/WNL.0b013e3182364a44","article-title":"Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome.","volume":"77","author":"Lancaster","year":"2011","journal-title":"Neurology"},{"key":"R25-19-20210206","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.pharmthera.2005.11.007","article-title":"Mechanisms of the adaptive immune response inside the central nervous system during inflammatory and autoimmune diseases.","volume":"111","author":"Pedemonte","year":"2006","journal-title":"Pharmacol Ther"},{"key":"R26-19-20210206","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1096\/fj.09-136200","article-title":"CD8 T cells and neuronal damage: direct and collateral mechanisms of cytotoxicity and impaired electrical excitability.","volume":"23","author":"Melzer","year":"2009","journal-title":"FASEB J"},{"key":"R27-19-20210206","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nri2529","article-title":"Losing your nerves Maybe its the antibodies.","volume":"9","author":"Diamond","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"R28-19-20210206","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1474-4422(11)70096-5","article-title":"Autoantibodies associated with diseases of the CNS: new developments and future challenges.","volume":"10","author":"Vincent","year":"2011","journal-title":"Lancet Neurol"},{"key":"R29-19-20210206","doi-asserted-by":"crossref","first-page":"15397","DOI":"10.1523\/JNEUROSCI.4339-09.2009","article-title":"Cytotoxic CD8 T cell-neuron interactions: perforin-dependent electrical silencing precedes but is not causally linked to neuronal cell death.","volume":"29","author":"Meuth","year":"2009","journal-title":"J Neurosci"},{"key":"R30-19-20210206","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1212\/WNL.0b013e318224afde","article-title":"Encephalitis and antibodies to synaptic and neuronal cell surface proteins.","volume":"77","author":"Lancaster","year":"2011","journal-title":"Neurology"},{"key":"R31-19-20210206","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1093\/brain\/awh247","article-title":"FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes.","volume":"127","author":"Younes-Mhenni","year":"2004","journal-title":"Brain"},{"key":"R32-19-20210206","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000312657","article-title":"Paraneoplastic neurological syndromes and the role of PET imaging.","volume":"78","author":"Sioka","year":"2010","journal-title":"Oncology"},{"key":"R33-19-20210206","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/1756285609349521","article-title":"Progress in the management of paraneoplastic neurological disorders.","volume":"3","author":"Sadeghian","year":"2010","journal-title":"Ther Adv Neurol Disord"},{"key":"R34-19-20210206","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1212\/WNL.0b013e318228c136","article-title":"Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis.","volume":"77","author":"Martinez-Hernandez","year":"2011","journal-title":"Neurology"}],"container-title":["Current Opinion in Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WCO.0b013e3283531efb","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T08:12:03Z","timestamp":1620979923000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00019052-201206000-00019"}},"subtitle":["entities, mechanisms, diagnostic clues, and therapeutic options"],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/wco.0b013e3283531efb","relation":{},"ISSN":["1350-7540"],"issn-type":[{"value":"1350-7540","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}